The study, published in The Journal of Hepatology, suggests that family members might also find value in the lifestyle guidance currently reserved for patients with fatty liver disease
The results, published in the online edition of The New England Journal of Medicine, describe a drug, called Pegozafermin, that mimics a hormone in the body and improves both liver fibrosis, or scarring of the liver, and liver inflammation in patients with NASH.
The Indian Institute of Technology (IIT) Mandi, researchers have unravelled the biochemical relationship between fatty liver disease and Type 2 Diabetes Mellitus (T2DM).
Boston: Researchers have projected the rates of liver disease and associated deaths due to increased alcohol consumption during the COVID-19 pandemic. The research has been published in the ‘Hepatology Journal’. A team led by investigators at Massachusetts General Hospital used data from a national survey of US adults on their drinking habits that found that […]
